|Articles|February 21, 2023

MMS Partners With I-ACT

Organizations to focus on development of children's clinical trials.

MMS Holdings has announced its partnership with the Institute for Advanced Clinical Trials (I-ACT) to develop children's therapeutics, including vaccines, medicines, and medical devices.

MMS is a sponsor of I-ACT’s Spin Challenge, which raises funds to advance children’s clinical trials. The event officially launches in early March when scores of pediatricians, pediatric nurses, pediatric social workers, and others will visit Disney World and set a world record by riding Disney’s Spinning Tea Cups for three days.

In addition to its corporate sponsorship, MMS colleagues participated in the challenge by “spinning” in their own way, some on bicycles, with hockey pucks, bowling balls, and more.

Reference

MMS Partners with I-ACT to Advance Children’s Clinical Trials. (2023, February 21). Business Wire.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!